Form 8-K - Current report:
SEC Accession No. 0001213900-24-071499
Filing Date
2024-08-21
Accepted
2024-08-21 16:55:50
Documents
17
Period of Report
2024-08-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0211953-8k_allarity.htm   iXBRL 8-K 42193
2 FORM OF CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SER ea021195301ex3-1_allarity.htm EX-3.1 116597
3 FORM OF SECURITIES PURCHASE AGREEMENT BETWEEN THE COMPANY AND THE INVESTORS THER ea021195301ex10-1_allarity.htm EX-10.1 245770
4 FORM OF REGISTRATION RIGHTS AGREEMENT BY AND AMONG THE COMPANY AND THE INVESTORS ea021195301ex10-2_allarity.htm EX-10.2 107651
5 SIXTH AMENDMENT TO EXCLUSIVE LICENSE AGREEMENT ea021195301ex10-3_allarity.htm EX-10.3 24990
  Complete submission text file 0001213900-24-071499.txt   834630

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE allr-20240819.xsd EX-101.SCH 3015
7 XBRL LABEL FILE allr-20240819_lab.xml EX-101.LAB 34240
8 XBRL PRESENTATION FILE allr-20240819_pre.xml EX-101.PRE 22359
19 EXTRACTED XBRL INSTANCE DOCUMENT ea0211953-8k_allarity_htm.xml XML 3915
Mailing Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108
Business Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108 401-426-4664
Allarity Therapeutics, Inc. (Filer) CIK: 0001860657 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41160 | Film No.: 241229312
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)